Rosen's Breast Pathology, 4e

934

Chapter 33

216. Velanovich V. Fine needle aspiration cytology in the diagnosis and management of ectopic breast tissue. Am Surg 1995;61:277–278. 217. Vargas J, Nevado M, Rodríguez-Peralto J, et al. Fine needle aspiration diagnosis of carcinoma arising in an ectopic breast. A case report. Acta Cytol 1995;39:941–944. 218. Paksoy N. Ectopic lesions as potential pitfalls in fine needle aspiration cytology: a report of 3 cases derived from the thyroid, endometrium and breast. Acta Cytol 2007;51:222–226. Inflammatory Carcinoma 219. Bell C. A systemof operative surgery, vol. 1. London: Longman, 1807:180. 220. Lee BJ, Tannenbaum E. Inflammatory carcinoma of the breast: a re­ port of twenty-eight cases from the breast clinic of the Memorial Hos­ pital. Surg Gynecol Obstet 1924;39:580–595. 221. Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual . 7th ed. New York: Springer, 2009:354–355. 222. Robertson FM, Bondy M, Yang W, et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin 2010;60:351–375. 223. Ellis DL, Teitelbaum SL. Inflammatory carcinoma of the breast. A pathologic definition. Cancer 1974;33:1045–1047. 224. Saltzstein SL. Clinically occult inflammatory carcinoma of the breast. Cancer 1974;34:382–388. 225. Levine PH, Steinhorn SC, Ries LG, et al. Inflammatory breast can­ cer: the experience of the surveillance, epidemiology, and end results (SEER) program. J Natl Cancer Inst 1985;74:291–297. 226. Chang S, Parker SL, Pham T, et al. Inflammatory breast carcinoma inci­ denceandsurvival:thesurveillance,epidemiology,andendresultsprogram of the National Cancer Institute, 1975–1992. Cancer 1998;82:2366–2372. 227. Il’yasova D, Siamakpour-Reihani S, Akushevich I, et al. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma? Breast Cancer Res Treat 2011;130:691–697. 228. Boussen H, Bouzaiene H, Ben Hassouna J, et al. Inflammatory breast cancer in Tunisia: epidemiological and clinical trends. Cancer 2010;116(11 Suppl.):2730–2735. 229. Chamadol W, Pesie M, Puapairoj A. Inflammatory carcinoma of the breast in a 12 year old Thai girl. J Med Assoc Thai 1987;70:543–547. 230. Nichini F, Holdman L, Lapayowker M, et al. Inflammatory carcinoma of the breast in a 12-year-old girl. Arch Surg 1972;105:505–508. 231. Treves N. Inflammatory carcinoma of the breast in a male patient. Surgery 1953;34:810–820. 232. Haagensen CD. Inflammatory carcinoma. In: Diseases of the breast , 2nd ed. Philadelphia: WB Saunders, 1971:576–584. 233. Stocks L, Patterson S. Inflammatory carcinoma of the breast. Surg ­Gynecol Obstet 1976;143:885–889. 234. Robbins GF, Shah J, Rosen P, et al. Inflammatory carcinoma of the breast. Surg Clin N Am 1974;54:801–810. 235. Barker JL, Nelson AJ III, Montague ED. Inflammatory carcinoma of the breast. Radiology 1976;121:173–176. 236. Droulias CA, Sewell CW, McSweeney MB, et al. Inflammatory carci­ noma of the breast. A correlation of clinical radiologic and pathologic findings. Ann Surg 1976;184:217–222. 237. Nussbaum H, Kagan AR, Gilbert H, et al. Management of inflamma­ tory breast carcinoma. Breast 1977;3:25–28. 238. Dershaw DD, Moore MP, Liberman L, et al. Inflammatory breast car­ cinoma: mammographic findings. Radiology 1994;190:831–834. 239. Tardivon AA, Viala J, Rudelli AC, et al. Mammographic patterns of inflammatory breast carcinoma: a retrospective study of 92 cases. Eur J Radiol 1997;24:124–130. 240. Kushwaha AC, Whitman GJ, Stelling CB, et al. Primary inflammatory carcinoma of the breast: retrospective review of mammographic find­ ings. AJR Am J Roentgenol 2000;174:535–538. 241. Gunhan-Bilgen I, Ustun EE, Memis A. Inflammatory breast carci­ noma: mammographic, ultrasonographic, clinical and pathologic findings in 142 cases. Radiology 2002;223:829–838. 242. Shukla HS, Hughes LE, Gravelle IH, et al. The significance of mam­ mary skin edema in noninflammatory breast cancer. Ann Surg 1979;89:53–57. 243. Le-Petross CH, Bidaut L, Yang WT. Evolving role of imaging modali­ ties in inflammatory breast cancer. Semin Oncol 2008;35:51–63. 244. Le-Petross HT, Cristofanilli M, Carkaci S, et al. MRI features of inflam­ matory breast cancer. AJR Am J Roentgenol 2011;197:W769–W776.

245. Piera JM, Alonso MC, Ojeda MB, et al. Locally advanced breast cancer with inflammatory component: a clinical entity with a poor prognosis. Radiother Oncol 1986;7:199–204. 246. Kokal WA, Hill RL, Porudominsky D, et al. Inflammatory breast car­ cinoma: a distinct entity? J Surg Oncol 1985;30:152–155. 247. Anderson WF, Chuk C, Chang S. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinico­ pathologic entities. J Clin Oncol 2003;21:2254–2259. 248. Charpin C, Bounier P, Khouzami A, et al. Inflammatory breast carci­ noma: an immunohistochemical study usingmonoclonal anti-pHER-2/ neu, pS2, cathepsin, ER and PR. Anticancer Res 1992;12:591–598. 249. Guerin M, Gabillot M, Mathieu M-C, et al. Structure and expres­ sion of c-erbB-2 and EGF receptor genes in inflammatory and non- inflammatory breast cancer: prognostic significance. Int J Cancer 1989;43:201–208. 250. Schäfer P, Alberto P, Forni M, et al. Surgery as part of a combined modality approach for inflammatory breast carcinoma. Cancer 1987;59:1063–1067. 251. Gong Y. Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights of its aggressive phenotype. Semin Oncol 2008; 35:33–40. 252. Alpaugh ML, Tomlinson JS, Shao ZM, et al. A novel human xenograft model of inflammatory breast cancer. Cancer Res 1999;59:5079–5084. 253. Resetkova E, Gonzalez-Angulo AM, Sneige N, et al. Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma. Cancer 2004;101:913–917. 254. Riou G, Le MG, Travagli JP, et al. Poor prognosis of p53 gene muta­ tion and nuclear overexpression of p53 protein in inflammatory breast carcinoma. J Natl Cancer Inst 1993;85:1765–1767. 255. Turpin E, Bieche I, Bertheau P, et al. Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer. Oncogene 2002;21:7593–7597. 256. Charafe-Jauffret E, Tarpin C, Bardou V-J, et al. Immunophenotypic analysis of inflammatory breast cancers: identification of an inflam­ matory signature. J Pathol 2004;202:265–273. 257. Vincent-Salomon A, Jouve M, Genin P, et al. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process. Cancer 2002;94:2169–2173. 258. Arens N, Bleyl U, Hildenbrand R. HER2/neu, p53, Ki67 and hormone receptors do not change during neoadjuvant chemotherapy in breast cancer. Virchows Arch 2005;446:489–496. 259. McCarthy NJ, Yang X, Linnoila IR, et al. Microvessel density, expres­ sion of estrogen receptor alpha, MIB-1, p53 and c-erbB-2 in inflam­ matory breast cancer. Clin Cancer Res 2002;8:3857–3862. 260. Colpaert CG, Vermeulen PB, Benou I, et al. Inflammatory breast can­ cer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br J Cancer 2003;88:718–725. 261. Bioche I, Lereboure F, Tozlu S, et al. Molecular profiling of inflamma­ tory breast cancer” Identification of a poor-prognosis gene expression signature. Clin Cancer Res 2004;10:6789–6795. 262. Kleer CG, vanGolen KL, Merajver SD. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res 2000;2:423–429. 263. Wedam SB, Low JA, Yang SX, et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally ad­ vanced breast cancer. J Clin Oncol 2006;24:769–777. 264. Guth U, Moch H, Herberich L, et al. Noninflammatory breast carci­ noma with skin involvement. Clinical diagnosis is relevant to appro­ priate classification in the TNM system. Cancer 2004;1000:470–478. 265. Tschen EH, Apisarnthanarax P. Inflammatory metastatic carcinoma of the breast. Arch Dermatol 1981;177:120–121. 266. Brownstein MH, Helwig EB. Spread of tumors to the skin. Arch Der- matol 1973;107:80–86. 267. Hazelrigg DC, Rudolph AH. Inflammatory metastatic carcinoma. Arch Dermatol 1977;113:69–70. 268. Meyer AC, Dockerty MB, Harrington SW. Inflammatory carcinoma of the breast. Surg Gynecol Obstet 1948;87:417–424. 269. Lucas FV, Perez-Mesa C. Inflammatory carcinoma of the breast. Can- cer 1978;41:1595–1605. 270. Kumar N, Sayed S, Moloo Z, et al. Fine-needle aspiration in suspected inflammatory breast cancer: case series with emphasis on approach to specimen adequacy. Acta Cytol 2011;55:239–244.